New drug combo tested in fight against Tough-to-Treat hodgkin lymphoma

NCT ID NCT05180097

Summary

This study is testing if a new combination of two drugs (pembrolizumab and brentuximab vedotin) works better than the current standard treatment for classical Hodgkin lymphoma that has come back or not responded to initial chemotherapy. The goal is to shrink or eliminate the cancer to prepare patients for a stem cell transplant. The trial will enroll 84 adults to compare the effectiveness and side effects of the two treatment approaches.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HODGKIN LYMPHOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Allan Blair Cancer Centre

    RECRUITING

    Regina, Saskatchewan, S4T 7T1, Canada

    Contact Phone: •••-•••-••••

  • Arthur J.E. Child Comprehensive Cancer Centre

    RECRUITING

    Calgary, Alberta, T2N 5G2, Canada

    Contact Phone: •••-•••-••••

  • Austin Hospital

    RECRUITING

    Heidelberg, Victoria, 3084, Australia

    Contact Phone: •••-•••-••••

  • BCCA - Vancouver

    RECRUITING

    Vancouver, British Columbia, V5Z 4E6, Canada

    Contact Phone: •••-•••-••••

  • CIUSSS de l'Estrie - Centre hospitalier

    RECRUITING

    Sherbrooke, Quebec, J1H 5N4, Canada

    Contact Phone: •••-•••-••••

  • Concord Repatriation General Hospital

    RECRUITING

    Concord, New South Wales, 2139, Australia

    Contact

  • Dr. H. Bliss Murphy Cancer Centre

    RECRUITING

    St. John's, Newfoundland and Labrador, A1B 3V6, Canada

    Contact Phone: •••-•••-••••

  • Juravinski Cancer Centre at Hamilton Health Sciences

    RECRUITING

    Hamilton, Ontario, L8V 5C2, Canada

    Contact Phone: •••-•••-••••

  • London Health Sciences Centre Research Inc.

    RECRUITING

    London, Ontario, N6A 5W9, Canada

    Contact Phone: •••-•••-••••

  • Ottawa Hospital Research Institute

    RECRUITING

    Ottawa, Ontario, K1H 8L6, Canada

    Contact Phone: •••-•••-••••

  • QEII Health Sciences Centre

    RECRUITING

    Halifax, Nova Scotia, B3H 1V7, Canada

    Contact Phone: •••-•••-••••

  • Royal Adelaide Hospital

    RECRUITING

    Adelaide, South Australia, 5000, Australia

    Contact Phone: •••-•••-••••

  • Shoalhaven Cancer Care Centre

    RECRUITING

    Nowra, New South Wales, 2541, Australia

    Contact

  • Sir Charles Gairdner Hospital

    RECRUITING

    Perth, Western Australia, 6009, Australia

    Contact

  • The Jewish General Hospital

    RECRUITING

    Montreal, Quebec, H3T 1E2, Canada

    Contact Phone: •••-•••-••••

  • The Research Institute of the McGill University

    RECRUITING

    Montreal, Quebec, H4A 3J1, Canada

    Contact Phone: •••-•••-••••

  • University Health Network

    RECRUITING

    Toronto, Ontario, M5G 2M9, Canada

    Contact Phone: •••-•••-••••

  • Wollongong Hospital

    RECRUITING

    Wollongong, New South Wales, 2500, Australia

    Contact

Conditions

Explore the condition pages connected to this study.